Literature DB >> 17041035

Analysis of proline reduction in the nosocomial pathogen Clostridium difficile.

Sarah Jackson1, Mary Calos, Andrew Myers, William T Self.   

Abstract

Clostridium difficile, a proteolytic strict anaerobe, has emerged as a clinically significant nosocomial pathogen in recent years. Pathogenesis is due to the production of lethal toxins, A and B, members of the large clostridial cytotoxin family. Although it has been established that alterations in the amino acid content of the growth medium affect toxin production, the molecular mechanism for this observed effect is not yet known. Since there is a paucity of information on the amino acid fermentation pathways used by this pathogen, we investigated whether Stickland reactions might be at the heart of its bioenergetic pathways. Growth of C. difficile on Stickland pairs yielded large increases in cell density in a limiting basal medium, demonstrating that these reactions are tied to ATP production. Selenium supplementation was required for this increase in cell yield. Analysis of genome sequence data reveals genes encoding the protein components of two key selenoenzyme reductases, glycine reductase and d-proline reductase (PR). These selenoenzymes were expressed upon the addition of the corresponding Stickland acceptor (glycine, proline, or hydroxyproline). Purification of the selenoenzyme d-proline reductase revealed a mixed complex of PrdA and PrdB (SeCys-containing) proteins. PR utilized only d-proline but not l-hydroxyproline, even in the presence of an expressed and purified proline racemase. PR was found to be independent of divalent cations, and zinc was a potent inhibitor of PR. These results show that Stickland reactions are key to the growth of C. difficile and that the mechanism of PR may differ significantly from that of previously studied PR from nonpathogenic species.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17041035      PMCID: PMC1698225          DOI: 10.1128/JB.01370-06

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  47 in total

1.  Activation of MMP-2 by Clostridium difficile toxin B in bovine smooth muscle cells.

Authors:  T Koike; M Kuzuya; T Asai; S Kanda; X W Cheng; K Watanabe; Y Banno; Y Nozawa; A Iguchi
Journal:  Biochem Biophys Res Commun       Date:  2000-10-14       Impact factor: 3.575

2.  Molecular analysis of the grd operon coding for genes of the glycine reductase and of the thioredoxin system from Clostridium sticklandii.

Authors:  A Graentzdoerffer; A Pich; J R Andreesen
Journal:  Arch Microbiol       Date:  2001-01       Impact factor: 2.552

3.  C. difficile: by the numbers.

Authors:  Laura Eggertson
Journal:  CMAJ       Date:  2004-11-02       Impact factor: 8.262

4.  Linkage between toxin production and purine biosynthesis in Clostridium difficile.

Authors:  Tsuneo Maegawa; Tadahiro Karasawa; Toshiko Ohta; Xingmin Wang; Haru Kato; Hideo Hayashi; Shinichi Nakamura
Journal:  J Med Microbiol       Date:  2002-01       Impact factor: 2.472

5.  Identification of D-proline reductase from Clostridium sticklandii as a selenoenzyme and indications for a catalytically active pyruvoyl group derived from a cysteine residue by cleavage of a proprotein.

Authors:  U C Kabisch; A Gräntzdörffer; A Schierhorn; K P Rücknagel; J R Andreesen; A Pich
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

6.  Suppression of toxin production in Clostridium difficile VPI 10463 by amino acids.

Authors:  Sture Karlsson; Lars G Burman; Thomas Åkerlund
Journal:  Microbiology       Date:  1999-07       Impact factor: 2.777

7.  Clostridium difficile toxin B activates the EGF receptor and the ERK/MAP kinase pathway in human colonocytes.

Authors:  Xi Na; Dezheng Zhao; Hon Wai Koon; Ho Kim; Johanna Husmark; Mary P Moyer; Charalabos Pothoulakis; J Thomas LaMont
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

8.  Selenium from selenium-rich Spirulina is less bioavailable than selenium from sodium selenite and selenomethionine in selenium-deficient rats.

Authors:  J Cases; V Vacchina; A Napolitano; B Caporiccio; P Besançon; R Lobinski; J M Rouanet
Journal:  J Nutr       Date:  2001-09       Impact factor: 4.798

Review 9.  Gly-X-Y tripeptide frequencies in collagen: a context for host-guest triple-helical peptides.

Authors:  J A Ramshaw; N K Shah; B Brodsky
Journal:  J Struct Biol       Date:  1998       Impact factor: 2.867

10.  Carbohydrate fermentation by Clostridium difficile.

Authors:  S Nakamura; S Nakashio; K Yamakawa; N Tanabe; S Nishida
Journal:  Microbiol Immunol       Date:  1982       Impact factor: 1.955

View more
  52 in total

Review 1.  Regulating the Intersection of Metabolism and Pathogenesis in Gram-positive Bacteria.

Authors:  Anthony R Richardson; Greg A Somerville; Abraham L Sonenshein
Journal:  Microbiol Spectr       Date:  2015-06

2.  Role of the global regulator Rex in control of NAD+ -regeneration in Clostridioides (Clostridium) difficile.

Authors:  Laurent Bouillaut; Thomas Dubois; Michael B Francis; Nadine Daou; Marc Monot; Joseph A Sorg; Abraham L Sonenshein; Bruno Dupuy
Journal:  Mol Microbiol       Date:  2019-04-02       Impact factor: 3.501

Review 3.  Role of the intestinal microbiota in resistance to colonization by Clostridium difficile.

Authors:  Robert A Britton; Vincent B Young
Journal:  Gastroenterology       Date:  2014-02-04       Impact factor: 22.682

Review 4.  Protein-Derived Cofactors Revisited: Empowering Amino Acid Residues with New Functions.

Authors:  Victor L Davidson
Journal:  Biochemistry       Date:  2018-03-06       Impact factor: 3.162

Review 5.  Integration of metabolism and virulence in Clostridium difficile.

Authors:  Laurent Bouillaut; Thomas Dubois; Abraham L Sonenshein; Bruno Dupuy
Journal:  Res Microbiol       Date:  2014-10-15       Impact factor: 3.992

6.  Proline-dependent regulation of Clostridium difficile Stickland metabolism.

Authors:  Laurent Bouillaut; William T Self; Abraham L Sonenshein
Journal:  J Bacteriol       Date:  2012-12-07       Impact factor: 3.490

7.  Clostridioides difficile uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrhea.

Authors:  Eric J Battaglioli; Vanessa L Hale; Jun Chen; Patricio Jeraldo; Coral Ruiz-Mojica; Bradley A Schmidt; Vayu M Rekdal; Lisa M Till; Lutfi Huq; Samuel A Smits; William J Moor; Yava Jones-Hall; Thomas Smyrk; Sahil Khanna; Darrell S Pardi; Madhusudan Grover; Robin Patel; Nicholas Chia; Heidi Nelson; Justin L Sonnenburg; Gianrico Farrugia; Purna C Kashyap
Journal:  Sci Transl Med       Date:  2018-10-24       Impact factor: 17.956

8.  A prominent glycyl radical enzyme in human gut microbiomes metabolizes trans-4-hydroxy-l-proline.

Authors:  B J Levin; Y Y Huang; S C Peck; Y Wei; A Martínez-Del Campo; J A Marks; E A Franzosa; C Huttenhower; E P Balskus
Journal:  Science       Date:  2017-02-10       Impact factor: 47.728

9.  Adaptive strategies and pathogenesis of Clostridium difficile from in vivo transcriptomics.

Authors:  Claire Janoir; Cécile Denève; Sylvie Bouttier; Frédéric Barbut; Sandra Hoys; Laxmee Caleechum; Diana Chapetón-Montes; Fátima C Pereira; Adriano O Henriques; Anne Collignon; Marc Monot; Bruno Dupuy
Journal:  Infect Immun       Date:  2013-07-29       Impact factor: 3.441

10.  Diverse Energy-Conserving Pathways in Clostridium difficile: Growth in the Absence of Amino Acid Stickland Acceptors and the Role of the Wood-Ljungdahl Pathway.

Authors:  Simonida Gencic; David A Grahame
Journal:  J Bacteriol       Date:  2020-09-23       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.